IMVT NASDAQ
Immunovant, Inc.
1W: +17.9%
1M: +15.7%
3M: +28.3%
YTD: +31.7%
1Y: +127.5%
3Y: +88.6%
5Y: +120.2%
$34.15
+0.02 (+0.06%)
Weekly Expected Move ±6.8%
$24
$26
$27
$29
$31
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-465M
Net Income
-43.9% YoY
$-431M
Free Cash Flow
-58.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-70.1%
ROA-64.4%
ROIC5988.5%
Valuation
P/E-13.4
P/B6.3
EV/EBITDA-4.3
Leverage
Debt/Equity0.00
Current Ratio11.16
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z21.19
Beneish M0.00